PITPNC1 Inhibitors
PITPNC1 inhibitors of phosphatidylinositol 3-kinase (PI3K), such as Wortmannin and LY294002, can suppress the PI3K/Akt signaling pathway, which plays a significant role in the regulation of numerous cellular functions, including those related to lipid signaling and metabolism. By inhibiting PI3K, these chemicals can indirectly affect the activity of proteins that operate within this pathway, potentially including PITPNC1.
SecinH3, as a cytohesin inhibitor, can affect ARF family GTPases, which are involved in regulating lipid signaling and membrane trafficking. This could alter the cellular context within which PITPNC1 operates. Similarly, the binding of Neomycin to phosphoinositides may perturb the lipid composition of cellular membranes, affecting the localization and function of a broad spectrum of proteins, including PITPNC1. The inhibitor of Phospholipase C can affect the generation of diacylglycerol and inositol triphosphate, secondary messengers in signaling pathways where PITPNC1 might be implicated. Compounds that affect autophagy, such as 3-Methyladenine, could also indirectly influence PITPNC1's role if it is involved in membrane trafficking or turnover.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Inhibits cytohesins, potentially affecting ARF family GTPases and related phospholipid signaling involving PITPNC1. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $27.00 $35.00 | 20 | |
Binds to phosphoinositides, potentially disrupting membrane interactions and signaling processes involving PITPNC1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which can alter phosphoinositide metabolism and potentially affect PITPNC1 functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of PI3K, potentially affecting phosphoinositide signaling and PITPNC1 activity. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
Inhibits PI3K-related pathways, which can affect autophagy and potentially PITPNC1-related processes. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Non-selectively binds to phosphatidylinositol, potentially disrupting PITPNC1-related signaling. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Activates PPARα, which can affect lipid metabolism and potentially alter PITPNC1 function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases, potentially affecting signaling cascades that may interact with PITPNC1. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Disrupts Golgi function, which can affect lipid trafficking and potentially impact PITPNC1 activity. | ||||||